Biondi Antonio, Grosso Giuseppe, Mistretta Antonio, Marventano Stefano, Toscano Chiara, Drago Filippo, Gangi Santi, Basile Francesco
BMC Surg. 2013;13 Suppl 2(Suppl 2):S12. doi: 10.1186/1471-2482-13-S2-S12. Epub 2013 Oct 8.
In the late '80s the successes of the laparoscopic surgery for gallbladder disease laid the foundations on the modern use of this surgical technique in a variety of diseases. In the last 20 years, laparoscopic colorectal surgery had become a popular treatment option for colorectal cancer patients.
Many studies emphasized on the benefits stating the significant advantages of the laparoscopic approach compared with the open surgery of reduced blood loss, early return of intestinal motility, lower overall morbidity, and shorter duration of hospital stay, leading to a general agreement on laparoscopic surgery as an alternative to conventional open surgery for colon cancer. The reduced hospital stay may also decrease the cost of the laparoscopic surgery for colorectal cancer, despite th higher operative spending compared with open surgery. The average reduction in total direct costs is difficult to define due to the increasing cost over time, making challenging the comparisons between studies conducted during a time range of more than 10 years. However, despite the theoretical advantages of laparoscopic surgery, it is still not considered the standard treatment for colorectal cancer patients due to technical limitations or the characteristics of the patients that may affect short and long term outcomes.
The laparoscopic approach to colectomy is slowly gaining acceptance for the management of colorectal pathology. Laparoscopic surgery for colon cancer demonstrates better short-term outcome, oncologic safety, and equivalent long-term outcome of open surgery. For rectal cancer, laparoscopic technique can be more complex depending on the tumor location. The advantages of minimally invasive surgery may translate better care quality for oncological patients and lead to increased cost saving through the introduction of active enhanced recovery programs which are likely cost-effective from the perspective of the hospital health-care providers.
20世纪80年代后期,腹腔镜胆囊手术的成功为该手术技术在多种疾病中的现代应用奠定了基础。在过去20年里,腹腔镜结直肠手术已成为结直肠癌患者的一种流行治疗选择。
许多研究强调了腹腔镜手术的益处,指出与开放手术相比,腹腔镜手术具有显著优势,如失血少、肠道蠕动恢复早、总体发病率低、住院时间短,这使得人们普遍认可腹腔镜手术可作为结肠癌传统开放手术的替代方案。尽管与开放手术相比,腹腔镜手术的手术费用较高,但住院时间的缩短可能会降低结直肠癌腹腔镜手术的成本。由于成本随时间增加,很难确定总直接成本的平均降低幅度,这使得对超过10年时间范围内进行的研究进行比较具有挑战性。然而,尽管腹腔镜手术具有理论上的优势,但由于技术限制或可能影响短期和长期结果的患者特征,它仍未被视为结直肠癌患者的标准治疗方法。
腹腔镜结肠切除术在结直肠疾病的治疗中逐渐被接受。结肠癌的腹腔镜手术显示出更好的短期效果、肿瘤学安全性以及与开放手术相当的长期效果。对于直肠癌,根据肿瘤位置,腹腔镜技术可能更复杂。微创手术的优势可能转化为肿瘤患者更好的护理质量,并通过引入积极的强化康复计划实现成本节约的增加,从医院医疗服务提供者的角度来看,这些计划可能具有成本效益。